Modulators of complement activation: a patent review (2008 - 2013).

Area of Science:

• Immunology
• Medicinal Chemistry
• Drug Discovery

Background:

• The complement system is an ancient, efficient defense mechanism crucial for immunity.
• Proper regulation of complement activation is vital for preventing disease.
• Uncontrolled complement activity can exacerbate pathological conditions.

Purpose of the Study:

• To critically review patent literature on complement therapeutic agents from 2008-2013.
• To identify novel macromolecules, peptides, and small molecules targeting the complement cascade.
• To assess the progress and future directions in complement modulation therapies.

Main Methods:

• Comprehensive analysis of patent literature published between 2008 and 2013.
• Categorization of therapeutic agents including macromolecules, polysaccharides, proteins, antibodies, peptides, and small organic compounds.
• Evaluation of the novelty and therapeutic potential of identified agents.

Main Results:

• Identification of diverse therapeutic agents including specific antibodies, macromolecules, and small molecules.
• Patents cover a range of approaches for modulating complement activation.
• Progress has been made in developing specific complement inhibitors.

Conclusions:

• Despite decades of research, specific complement cascade inhibitors remain a significant challenge in medicinal chemistry.
• Existing macromolecule-based complement modulators show promise, but new, more efficient alternatives are needed.
• Further exploration in antibody-mediated inhibition and small molecule development is crucial for chronic complement-related disease management.